These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33621144)

  • 1. Gene editing technology: Towards precision medicine in inherited retinal diseases.
    Ballios BG; Pierce EA; Huckfeldt RM
    Semin Ophthalmol; 2021 May; 36(4):176-184. PubMed ID: 33621144
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR genome engineering for retinal diseases.
    Kantor A; McClements ME; Peddle CF; Fry LE; Salman A; Cehajic-Kapetanovic J; Xue K; MacLaren RE
    Prog Mol Biol Transl Sci; 2021; 182():29-79. PubMed ID: 34175046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing: the breakthrough technology for inherited retinal disease?
    Smith AJ; Carter SP; Kennedy BN
    Expert Opin Biol Ther; 2017 Oct; 17(10):1245-1254. PubMed ID: 28695744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome Surgery and Gene Therapy in Retinal Disorders.
    Chan L; Mahajan VB; Tsang SH
    Yale J Biol Med; 2017 Dec; 90(4):523-532. PubMed ID: 29259518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome editing, a superior therapy for inherited retinal diseases.
    Yan AL; Du SW; Palczewski K
    Vision Res; 2023 May; 206():108192. PubMed ID: 36804635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Application of CRISPR/Cas9 for the Treatment of Retinal Diseases.
    Peddle CF; MacLaren RE
    Yale J Biol Med; 2017 Dec; 90(4):533-541. PubMed ID: 29259519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in pre-clinical development of gene editing-based therapies to treat inherited retinal diseases.
    Chirco KR; Martinez C; Lamba DA
    Vision Res; 2023 Aug; 209():108257. PubMed ID: 37210864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Gene Editing in Inherited Retinal Disorders.
    Ling J; Jenny LA; Zhou A; Tsang SH
    Cold Spring Harb Perspect Med; 2023 Apr; 13(4):. PubMed ID: 36096547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy and genome surgery in the retina.
    DiCarlo JE; Mahajan VB; Tsang SH
    J Clin Invest; 2018 Jun; 128(6):2177-2188. PubMed ID: 29856367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences.
    Fry LE; Peddle CF; Barnard AR; McClements ME; MacLaren RE
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo genome editing for inherited retinal disease: Opportunities and challenges.
    Collin RWJ; Leroy BP
    Mol Ther; 2024 Aug; 32(8):2433-2434. PubMed ID: 39084223
    [No Abstract]   [Full Text] [Related]  

  • 13. Challenges to Gene Editing Approaches in the Retina.
    Bonillo M; Pfromm J; Fischer MD
    Klin Monbl Augenheilkd; 2022 Mar; 239(3):275-283. PubMed ID: 35316854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
    Hansen S; McClements ME; Corydon TJ; MacLaren RE
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision Therapy for Inherited Retinal Disease: At the Forefront of Genomic Medicine.
    Koulisis N; Nagiel A
    Clin Lab Med; 2020 Jun; 40(2):189-204. PubMed ID: 32439068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases.
    Chuang K; Fields MA; Del Priore LV
    Yale J Biol Med; 2017 Dec; 90(4):635-642. PubMed ID: 29259527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR in the Retina: Evaluation of Future Potential.
    Cho GY; Justus S; Sengillo JD; Tsang SH
    Adv Exp Med Biol; 2017; 1016():147-155. PubMed ID: 29130158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR Cas9 based genome editing in inherited retinal dystrophies.
    Bansal M; Acharya S; Sharma S; Phutela R; Rauthan R; Maiti S; Chakraborty D
    Ophthalmic Genet; 2021 Aug; 42(4):365-374. PubMed ID: 33821751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders.
    Benati D; Leung A; Perdigao P; Toulis V; van der Spuy J; Recchia A
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.